Glaucoma Drugs and Updates

Tuesday, June 30th, 5:30 PM PDT   

Presented by Pinakin Davey, OD, PhD, FAAO

COPE # 67871-GL     1 HR     $10.00

Description: 

This course covers the new drugs and new modalities of treatment that are FDA approved in the last 2-3 years. This course will also discuss pivotal studies that provide new clinical information about the selective laser trabeculoplasty and its use in open angle glaucoma and ocular hypertension.

Course learning objectives: 

This highly interactive course will cover current and latest development in the field. There will time to ask specific, detailed questions on topics covered and interest to the participants.

• • • • Understand and recollect the mechanism of action of nitric oxide donating drugs
      • Understand and recollect the IOP lowering effects, side effects profile and dose requirements of latanoprostene bunod
      • Understand and recollect the mechanism of action of rho kinase inhibitors and fixed combination of netarsudil and latanoprost
      • Understand and recollect the IOP lowering effects, side effects profile and dose requirements of rho kinase inhibitors and fixed combination of netarsudil and latanoprost
      • recollect the dose response of intracameral bimatoprost injection and clinical application
      • Understand the new LIGHT trials about efficacy and retreatment of Selective laser trabeculoplasty

Click HERE to Register